Skip to main content

Table 1 Pathological type distribution of epithelial ovarian carcinoma patients

From: Does serum CA125 have clinical value for follow-up monitoring of postoperative patients with epithelial ovarian cancer? Results of a 12-year study

Category Pathology staging  
I II III IV Total
Serous cystadenocarcinoma 15(7.8) 23(12.0) 145(75.5) 9(4.7) 192(56.1)
Mucinous cystadenocarcinoma 9(34.6) 3(11.5) 14(53.9) 0(0) 26(7.6)
Endometrial adenocarcinoma 11(34.4) 5(15.6) 16(50.0) 0(0) 32(9.4)
Clear cell carcinoma 19(82.6) 0(0) 4(17.4) 0(0) 23(6.7)
Mixed type and undifferentiated carcinoma 26(37.7) 24(34.8) 19(27.5) 0(0) 69(20.2)
Total 80(23.4) 55(16.1) 198(57.9) 9(2.6) 342(100.0)